Thus, the restoration of the primary cilia may be a potential therapeutic approach for CCA, and HDAC6 inhibitors may be important agents for the treatment of other ciliopathy-related diseases [77]. The gene discussed is HDAC6; the disease is cholangiocarcinoma.